DMAC
Price
$4.09
Change
-$0.11 (-2.62%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
175.39M
61 days until earnings call
WHWK
Price
$1.67
Change
-$0.03 (-1.78%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
79.14M
62 days until earnings call
Interact to see
Advertisement

DMAC vs WHWK

Header iconDMAC vs WHWK Comparison
Open Charts DMAC vs WHWKBanner chart's image
DiaMedica Therapeutics
Price$4.09
Change-$0.11 (-2.62%)
Volume$643
Capitalization175.39M
Whitehawk Therapeutics
Price$1.67
Change-$0.03 (-1.78%)
Volume$300
Capitalization79.14M
DMAC vs WHWK Comparison Chart
Loading...
DMAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DMAC vs. WHWK commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMAC is a StrongBuy and WHWK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (DMAC: $4.09 vs. WHWK: $1.68)
Brand notoriety: DMAC and WHWK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DMAC: 108% vs. WHWK: 75%
Market capitalization -- DMAC: $175.39M vs. WHWK: $79.14M
DMAC [@Biotechnology] is valued at $175.39M. WHWK’s [@Biotechnology] market capitalization is $79.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DMAC’s FA Score shows that 0 FA rating(s) are green whileWHWK’s FA Score has 0 green FA rating(s).

  • DMAC’s FA Score: 0 green, 5 red.
  • WHWK’s FA Score: 0 green, 5 red.
According to our system of comparison, WHWK is a better buy in the long-term than DMAC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DMAC’s TA Score shows that 6 TA indicator(s) are bullish while WHWK’s TA Score has 5 bullish TA indicator(s).

  • DMAC’s TA Score: 6 bullish, 2 bearish.
  • WHWK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DMAC is a better buy in the short-term than WHWK.

Price Growth

DMAC (@Biotechnology) experienced а -2.39% price change this week, while WHWK (@Biotechnology) price change was -6.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

DMAC is expected to report earnings on Aug 06, 2025.

WHWK is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DMAC($175M) has a higher market cap than WHWK($79.1M). DMAC YTD gains are higher at: -24.678 vs. WHWK (-46.434). WHWK has higher annual earnings (EBITDA): 27.9M vs. DMAC (-24.07M). WHWK has more cash in the bank: 231M vs. DMAC (50.2M). WHWK has less debt than DMAC: WHWK (0) vs DMAC (365K). WHWK has higher revenues than DMAC: WHWK (27.8M) vs DMAC (0).
DMACWHWKDMAC / WHWK
Capitalization175M79.1M221%
EBITDA-24.07M27.9M-86%
Gain YTD-24.678-46.43453%
P/E RatioN/A11.20-
Revenue027.8M-
Total Cash50.2M231M22%
Total Debt365K0-
FUNDAMENTALS RATINGS
DMAC vs WHWK: Fundamental Ratings
DMAC
WHWK
OUTLOOK RATING
1..100
203
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
42
Fair valued
PROFIT vs RISK RATING
1..100
9695
SMR RATING
1..100
9449
PRICE GROWTH RATING
1..100
6280
P/E GROWTH RATING
1..100
10054
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WHWK's Valuation (42) in the Pharmaceuticals Major industry is in the same range as DMAC (62) in the Biotechnology industry. This means that WHWK’s stock grew similarly to DMAC’s over the last 12 months.

WHWK's Profit vs Risk Rating (95) in the Pharmaceuticals Major industry is in the same range as DMAC (96) in the Biotechnology industry. This means that WHWK’s stock grew similarly to DMAC’s over the last 12 months.

WHWK's SMR Rating (49) in the Pharmaceuticals Major industry is somewhat better than the same rating for DMAC (94) in the Biotechnology industry. This means that WHWK’s stock grew somewhat faster than DMAC’s over the last 12 months.

DMAC's Price Growth Rating (62) in the Biotechnology industry is in the same range as WHWK (80) in the Pharmaceuticals Major industry. This means that DMAC’s stock grew similarly to WHWK’s over the last 12 months.

WHWK's P/E Growth Rating (54) in the Pharmaceuticals Major industry is somewhat better than the same rating for DMAC (100) in the Biotechnology industry. This means that WHWK’s stock grew somewhat faster than DMAC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DMACWHWK
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 17 days ago
79%
Declines
ODDS (%)
Bearish Trend 15 days ago
82%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DMAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BPAVX31.19N/A
N/A
Boston Partners All Cap Value Inv
BGORX21.89N/A
N/A
BlackRock Advantage International R
UGMVX11.52N/A
N/A
Victory Global Managed Volatility
GMVAX15.56N/A
N/A
Goldman Sachs Small/Mid Cap Value A
PETGX14.70N/A
N/A
Gabelli Pet Parents'™ A

WHWK and

Correlation & Price change

A.I.dvisor indicates that over the last year, WHWK has been loosely correlated with AXON. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if WHWK jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WHWK
1D Price
Change %
WHWK100%
-0.59%
AXON - WHWK
44%
Loosely correlated
+2.76%
DMAC - WHWK
44%
Loosely correlated
+1.94%
AMRN - WHWK
37%
Loosely correlated
-0.88%
ARRY - WHWK
36%
Loosely correlated
-0.43%
IPSC - WHWK
36%
Loosely correlated
-0.54%
More